Literature DB >> 17870136

Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent.

K Stachowicz1, K Gołembiowska, M Sowa, G Nowak, E Chojnacka-Wójcik, A Pilc.   

Abstract

The purpose of the present study was to investigate whether the anxiolytic-like action of a selective and brain penetrable group I metabotropic glutamate (mGlu5) receptor antagonist 3-[(2-methyl-1,3-tiazol-4-yl)ethynyl]-pyridine (MTEP) is dependent upon the serotonergic system. Experiments were performed on male Wistar rats. The Vogel conflict drinking test was used to detect anxiolytic-like activity. MTEP administered intraperitoneally at doses of 1, 3 and 6 mg/kg induced anxiolytic-like effect. The potential anxiolytic effect of MTEP (1 mg/kg) was inhibited by a nonselective 5-HT receptor antagonist metergoline (2 mg/kg i.p.) and 5-HT2A/2C receptor antagonist ritanserin (0.5 mg/kg i.p.), but not by a 5-HT1A receptor antagonist N-{2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl}-N-(2-pyridynyl)cyclohexane-carboxamide (WAY 100635) (0.1 mg/kg i.p). The anxiolytic effect of MTEP (6 mg/kg) was attenuated by ritanserin (1 mg/kg i.p.). Moreover, MTEP-induced a dose-dependent release of serotonin in the frontal cortex. The obtained results suggest that the potential anxiolytic effect of the mGlu5 receptor antagonist MTEP is due to the increased serotonin release with subsequent activation of 5-HT2A/2C receptors, most probably located postsynaptically, but not by the 5-HT1A receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17870136     DOI: 10.1016/j.neuropharm.2007.08.002

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  12 in total

1.  In vivo positron emission tomography imaging with [¹¹C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons.

Authors:  Christine DeLorenzo; Matthew S Milak; Kathleen G Brennan; J S Dileep Kumar; J John Mann; Ramin V Parsey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-29       Impact factor: 9.236

2.  Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test.

Authors:  Kenichi Fukumoto; Michihiko Iijima; Shigeyuki Chaki
Journal:  Psychopharmacology (Berl)       Date:  2014-01-09       Impact factor: 4.530

3.  The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent.

Authors:  Agnieszka Pałucha-Poniewiera; Piotr Brański; Joanna M Wierońska; Katarzyna Stachowicz; Anna Sławińska; Andrzej Pilc
Journal:  Psychopharmacology (Berl)       Date:  2014-01       Impact factor: 4.530

4.  Negative versus positive allosteric modulation of metabotropic glutamate receptors (mGluR5): indices for potential pro-cognitive drug properties based on EEG network oscillations and sleep-wake organization in rats.

Authors:  A Ahnaou; X Langlois; T Steckler; J M Bartolome-Nebreda; W H I M Drinkenburg
Journal:  Psychopharmacology (Berl)       Date:  2014-10-18       Impact factor: 4.530

5.  On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039.

Authors:  Agnieszka Pałucha-Poniewiera; Joanna M Wierońska; Piotr Brański; Katarzyna Stachowicz; Shigeyuki Chaki; Andrzej Pilc
Journal:  Psychopharmacology (Berl)       Date:  2010-08-12       Impact factor: 4.530

Review 6.  Metabotropic glutamate receptor 5 - a promising target in drug development and neuroimaging.

Authors:  Rajapillai L I Pillai; Dnyanesh N Tipre
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-07       Impact factor: 9.236

Review 7.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

Review 8.  Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety.

Authors:  R E Nordquist; T Steckler; J G Wettstein; C Mackie; W Spooren
Journal:  Psychopharmacology (Berl)       Date:  2008-03-06       Impact factor: 4.530

Review 9.  Metabotropic glutamate receptors: from the workbench to the bedside.

Authors:  F Nicoletti; J Bockaert; G L Collingridge; P J Conn; F Ferraguti; D D Schoepp; J T Wroblewski; J P Pin
Journal:  Neuropharmacology       Date:  2010-10-29       Impact factor: 5.250

10.  Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice.

Authors:  Adam L Halberstadt; Virginia D Lehmann-Masten; Mark A Geyer; Susan B Powell
Journal:  Psychopharmacology (Berl)       Date:  2010-12-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.